An analysis in the Proceedings of the National Academy of Sciences shows that in some countries, poor people aren't necessarily as unhealthy as you'd think--at least compared to U.S. poor.

While lobbyists helping write legislation isn't new, the level of cooperation between the FDA and the medical device industry on the 21st Century Cures bill is raising concerns.

Generic drug prices haven't increased much--but that don't insulate patients or insurers from outlier price hikes in pharmaceuticals.

The FDA is beginning to regulate how genetic testing companies market DNA tests for health insights, saying that genetic tests can establish paternity or indicate rare diseases, but for heart disease or diabetes, their value is less clear.

Younger replacement patients are more likely to have chronic health problems.

The Food and Drug Administration today warned that two drugs with similar names have been mixed up dozens of times by doctors and pharmacists.

Consumers might not notice it, but the price for health care has grown more slowly than other costs.

A new GAO report finds that HealthCare.gov lets fake people re-enroll.